<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38136038</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>22</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>"Multisystem Inflammatory Syndrome in Children"-Like Disease after COVID-19 Vaccination (MIS-V) with Potential Significance of Functional Active Autoantibodies Targeting G-Protein-Coupled Receptors (GPCR-fAAb) for Pathophysiology and Therapy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1836</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children10121836</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">An infection with SARS-CoV-2 can trigger a systemic disorder by pathological autoimmune processes. A certain type of this dysregulation is known as Multisystemic inflammatory syndrome in children (MIS-C). However, similar symptoms may occur and have been described as Multisystemic inflammatory syndrome after SARS-CoV-2 Vaccination (MIS-V) following vaccination against SARS-CoV-2. We report the case of a 12-year-old boy who was identified with MIS-C symptoms without previous SARS-CoV-2 infection after receiving two doses of the Pfizer-BioNTech COVID-19 vaccine approximately one month prior to the onset of symptoms. He showed polyserositis, severe gastrointestinal symptoms and, consequently, a manifestation of a multiorgan failure. IgG antibodies against spike proteins of SARS-CoV-2 were detected, indicating a successful vaccination, while SARS-CoV-2 Nucleocapsid protein antibodies and SARS-CoV-2 PCR were not detected. Several functional, active autoantibodies against G-protein-coupled receptors (GPCR-fAAb), previously associated with Long COVID disease, were detected in a cardiomyocyte bioassay. Immunosuppression with steroids was initiated. Due to side effects, treatment with steroids and later interleukin 1 receptor antagonists had to be terminated. Instead, immunoadsorption was performed and continued with tacrolimus and mycophenolic acid therapy, leading to improvement and discharge after 79 days. GPCR-fAAb decreased during therapy and remained negative after clinical curing and under continued immunosuppressive therapy with tacrolimus and mycophenolic acid. Follow-up of the patient showed him in good condition after one year.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Infection with SARS-CoV-2 shows a broad and severe variety of symptoms, partly due to autoimmune dysregulation, which, in some instances, can lead to multiorgan failure. Despite its rarity, post-vaccine MIS-C-like disease may develop into a serious condition triggered by autoimmune dysregulation. The evidence of circulating GPCR-fAAb and their disappearance after therapy suggests a link of GPCR-fAAb to the clinical manifestations. Thus, we hypothesize a potential role of GPCR-fAAb in pathophysiology and their potential importance for the therapy of MIS-C or MIS-V. However, this observation needs further investigation to prove a causative correlation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Marius</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe9;bert</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallukat</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Berlin Cures GmbH, 13125 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponader</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, 95032 Hof, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krickau</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galiano</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reutter</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3591-5265</Identifier><AffiliationInfo><Affiliation>Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woelfle</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agaimy</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0445-8161</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mardin</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University Hospital Erlangen, 90766 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoerning</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Immunotherapy, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hohberger</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2546-5504</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, University Hospital Erlangen, 90766 Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Immunotherapy, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">GPCR-fAAb</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">MIS-V</Keyword><Keyword MajorTopicYN="N">PIMS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Author Gerd Wallukat was employed by the company Berlin Cures GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38136038</ArticleId><ArticleId IdType="pmc">PMC10741397</ArticleId><ArticleId IdType="doi">10.3390/children10121836</ArticleId><ArticleId IdType="pii">children10121836</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee I.T., Lin P.J., Yen H.H. Pediatric Neuroimaging Findings and Clinical Presentations of COVID-19: A Systematic Review. Int. J. Infect. Dis. 2023 doi: 10.1016/j.ijid.2023.11.006. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.11.006</ArticleId><ArticleId IdType="pubmed">37944584</ArticleId></ArticleIdList></Reference><Reference><Citation>Cersosimo A., Di Pasquale M., Arabia G., Metra M., Vizzardi E. COVID myocarditis: A review of the literature. Monaldi Arch. Chest Dis. 2023 doi: 10.4081/monaldi.2023.2784. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2023.2784</ArticleId><ArticleId IdType="pubmed">37930657</ArticleId></ArticleIdList></Reference><Reference><Citation>Magar S.T., Gyawali B.R. Otorhinolaryngological and Ophthalmological Manifestations of COVID-19 in the Pediatric Population. JNMA J. Nepal. Med. Assoc. 2020;58:1093&#x2013;1096. doi: 10.31729/jnma.5450.</Citation><ArticleIdList><ArticleId IdType="doi">10.31729/jnma.5450</ArticleId><ArticleId IdType="pmc">PMC8028516</ArticleId><ArticleId IdType="pubmed">34506381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanowicz P., Dopytalska K., Szczerba M., Szyma&#x144;ska E., Walecka I. Dermatological manifestations of the Coronavirus disease 2019 in children: A systemic review. Postep. Dermatol. Alergol. 2022;39:491&#x2013;508. doi: 10.5114/ada.2020.99294.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ada.2020.99294</ArticleId><ArticleId IdType="pmc">PMC9326916</ArticleId><ArticleId IdType="pubmed">35950134</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurugubelli K.R., Bhat B.V. Coronavirus Disease 2019 Infection among Children: Pathogenesis, Treatment, and Outcome. J. Pediatr. Intensive Care. 2021;10:167&#x2013;173. doi: 10.1055/s-0040-1718417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1718417</ArticleId><ArticleId IdType="pmc">PMC8354362</ArticleId><ArticleId IdType="pubmed">34395033</ArticleId></ArticleIdList></Reference><Reference><Citation>Castaldo P., d&#x2019;Alanno G., Biserni G.B., Moratti M., Conti F., Fabi M., Lanari M. Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children. Pathogens. 2023;12:997. doi: 10.3390/pathogens12080997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12080997</ArticleId><ArticleId IdType="pmc">PMC10458149</ArticleId><ArticleId IdType="pubmed">37623957</ArticleId></ArticleIdList></Reference><Reference><Citation>Bregel L.V., Efremova O.S., Kostyunin K.Y., Rudenko N.Y., Kozlov Y.A., Albot V.V., Knyzeva N.A., Tolmacheva O.V., Ovanesyan S.V., Barakin A.O., et al. Thrombosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children: Retrospective Cohort Study Analysis and Review of the Literature. Biomedicines. 2023;11:2206. doi: 10.3390/biomedicines11082206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082206</ArticleId><ArticleId IdType="pmc">PMC10452691</ArticleId><ArticleId IdType="pubmed">37626703</ArticleId></ArticleIdList></Reference><Reference><Citation>Oragui C.C. Cardiovascular Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19. Cureus. 2023;15:e41950. doi: 10.7759/cureus.41950.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.41950</ArticleId><ArticleId IdType="pmc">PMC10426319</ArticleId><ArticleId IdType="pubmed">37588330</ArticleId></ArticleIdList></Reference><Reference><Citation>Shati A.A., Mahmood S.E., Alsuheel Asseri A., Alhanshani A.A., Alqahtani Y.A., Ahmad A. SARS-CoV-2 infections and MIS-C among children: A narrative review. Medicine. 2023;102:e34475. doi: 10.1097/MD.0000000000034475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000034475</ArticleId><ArticleId IdType="pmc">PMC10402996</ArticleId><ArticleId IdType="pubmed">37543809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazizadeh Esslami G., Mamishi S., Pourakbari B., Mahmoudi S. Systematic review and meta-analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection. J. Med. Virol. 2023;95:e28927. doi: 10.1002/jmv.28927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28927</ArticleId><ArticleId IdType="pubmed">37436781</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf A.R., Cortese M.M., Taylor A.W., Broder K.R., Oster M.E., Wong J.M., Guh A.Y., McCormick D.W., Kamidani S., Schlaudecker E.P., et al. Reported cases of multisystem inflammatory syndrome in children aged 12&#x2013;20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: A surveillance investigation. Lancet Child Adolesc. Health. 2022;6:303&#x2013;312. doi: 10.1016/S2352-4642(22)00028-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00028-1</ArticleId><ArticleId IdType="pmc">PMC8864018</ArticleId><ArticleId IdType="pubmed">35216660</ArticleId></ArticleIdList></Reference><Reference><Citation>McGann P.H., Krim A.O., Green J., Venturas J. Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination. Clin. Infect. Pract. 2022;14:100139. doi: 10.1016/j.clinpr.2022.100139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinpr.2022.100139</ArticleId><ArticleId IdType="pmc">PMC8843319</ArticleId><ArticleId IdType="pubmed">35187466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune A., Iyengar K.P., Goddard C., Ahmed A.E. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V) BMJ Case Rep. 2021;14:e243888. doi: 10.1136/bcr-2021-243888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-243888</ArticleId><ArticleId IdType="pmc">PMC8323360</ArticleId><ArticleId IdType="pubmed">34326117</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsaid M., Nune A., Hesham D., Fouad F.M., Hassan H., Hamouda H., Sherif H., Abdelwahab M.M., Hegazi N., El-Rahman Y.A. Multisystem Inflammatory Syndrome (MIS) following SARS-CoV-2 vaccinations: A systematic review. Trop. Dis. Travel Med. Vaccines. 2023;9:19. doi: 10.1186/s40794-023-00204-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40794-023-00204-x</ArticleId><ArticleId IdType="pmc">PMC10625711</ArticleId><ArticleId IdType="pubmed">37925466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.-S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Asher A., Tintle N.L., Myers M., Lockshon L., Bacareza H., Harris W.S. Blood omega-3 fatty acids and death from COVID-19: A pilot study. Prostaglandins Leukot. Essent. Fat. Acids. 2021;166:102250. doi: 10.1016/j.plefa.2021.102250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2021.102250</ArticleId><ArticleId IdType="pmc">PMC7816864</ArticleId><ArticleId IdType="pubmed">33516093</ArticleId></ArticleIdList></Reference><Reference><Citation>Poggioli R., Hirani K., Jogani V.G., Ricordi C. Modulation of inflammation and immunity by omega-3 fatty acids: A possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders. Eur. Rev. Med. Pharmacol. Sci. 2023;27:7380&#x2013;7400. doi: 10.26355/eurrev_202308_33310.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202308_33310</ArticleId><ArticleId IdType="pubmed">37606147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.S., Soto-Diaz K., Bingham T.W., Steelman A.J., Das A. Role of omega-3 endocannabinoids in the modulation of T-cell activity in a multiple sclerosis experimental autoimmune encephalomyelitis (EAE) model. J. Biol. Chem. 2023;299:102886. doi: 10.1016/j.jbc.2023.102886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.102886</ArticleId><ArticleId IdType="pmc">PMC9926309</ArticleId><ArticleId IdType="pubmed">36626985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtari T., Hassani F., Ghaffari N., Ebrahimi B., Yarahmadi A., Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. Histochem. J. 2020;51:613&#x2013;628. doi: 10.1007/s10735-020-09915-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10735-020-09915-3</ArticleId><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamoorthy Y., Karunakaran M., Ganesh K., Hariharan V.S. Association between acute liver injury &amp; severity and mortality of COVID-19 patients: A systematic review and meta-analysis. Heliyon. 2023;9:e20338. doi: 10.1016/j.heliyon.2023.e20338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e20338</ArticleId><ArticleId IdType="pmc">PMC10560047</ArticleId><ArticleId IdType="pubmed">37809564</ArticleId></ArticleIdList></Reference><Reference><Citation>Forero K., Buqaileh R., Sunderman C., AbouAlaiwi W. COVID-19 and Neurological Manifestations. Brain Sci. 2023;13:1137. doi: 10.3390/brainsci13081137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13081137</ArticleId><ArticleId IdType="pmc">PMC10452375</ArticleId><ArticleId IdType="pubmed">37626493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilehjani E., Fakhari S., Farzin H., Tajlil A., Nader N.D. Diagnosis and treatment of cardiovascular manifestations of COVID-19: A narrative review. Acta Cardiol. 2023 doi: 10.1080/00015385.2023.2246200. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00015385.2023.2246200</ArticleId><ArticleId IdType="pubmed">37606350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi K., Rai P., Gautam A., Kaur H., Kapoor S., Suttee A., Jaiswal P.K., Sharma A., Singh G., Barnwal R.P. Neurological manifestations of SARS-CoV-2: Complexity, mechanism and associated disorders. Eur. J. Med. Res. 2023;28:307. doi: 10.1186/s40001-023-01293-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-023-01293-2</ArticleId><ArticleId IdType="pmc">PMC10469568</ArticleId><ArticleId IdType="pubmed">37649125</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain B., Malik F., Khan A., Abidi M., Marhaba A., Oranu A., Shumeyko M., Hila A., Banks L., Patel O.A., et al. Prevalence and Impact of Gastrointestinal Manifestations in COVID-19 Patients: A Systematic Review. J. Community Hosp. Intern. Med. Perspect. 2023;13:39&#x2013;54. doi: 10.55729/2000-9666.1145.</Citation><ArticleIdList><ArticleId IdType="doi">10.55729/2000-9666.1145</ArticleId><ArticleId IdType="pmc">PMC10593163</ArticleId><ArticleId IdType="pubmed">37877065</ArticleId></ArticleIdList></Reference><Reference><Citation>Va&#x148;kov&#xe1; L., Bufka J., K&#x159;&#xed;&#x17e;kov&#xe1; V. Pathophysiological and clinical point of view on Kawasaki disease and MIS-C. Pediatr. Neonatol. 2023;64:495&#x2013;504. doi: 10.1016/j.pedneo.2023.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2023.05.002</ArticleId><ArticleId IdType="pmc">PMC10286520</ArticleId><ArticleId IdType="pubmed">37453902</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara J., Watanabe K., Takagi H., Sumitomo N., Kuno T. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis. Pediatr. Pulmonol. 2021;56:837&#x2013;848. doi: 10.1002/ppul.25245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25245</ArticleId><ArticleId IdType="pmc">PMC8013394</ArticleId><ArticleId IdType="pubmed">33428826</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak A., Perdas E., Smolewska E. Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19. Eur. J. Pediatr. 2022;181:3733&#x2013;3738. doi: 10.1007/s00431-022-04584-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04584-8</ArticleId><ArticleId IdType="pmc">PMC9364844</ArticleId><ArticleId IdType="pubmed">35948653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu A., Maji S., Kumar S., Bhattacharya S., Chakraborty P., Sarkar J. Clinical aspects and presumed etiology of multisystem inflammatory syndrome in children (MIS-C): A review. Clin. Epidemiol. Glob. Health. 2022;14:100966. doi: 10.1016/j.cegh.2022.100966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2022.100966</ArticleId><ArticleId IdType="pmc">PMC8810427</ArticleId><ArticleId IdType="pubmed">35132389</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos M.O., Gon&#xe7;alves L.C., Silva P.A., Moreira A.L., Ito C.R., Peixoto F.A.O., Wastowski I.J., Carneiro L.C., Avelino M.A. Multisystem inflammatory syndrome (MIS-C): A systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J. Pediatr. 2021;98:338&#x2013;349. doi: 10.1016/j.jped.2021.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2021.08.006</ArticleId><ArticleId IdType="pmc">PMC9432310</ArticleId><ArticleId IdType="pubmed">34863701</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation . Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19. World Health Organisation; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Karatzios C., Scuccimarri R., Ch&#xe9;deville G., Basfar W., Bullard J., Stein D.R. Multisystem Inflammatory Syndrome following SARS-CoV-2 Vaccination in Two Children. Pediatrics. 2022;150:e2021055956. doi: 10.1542/peds.2021-055956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-055956</ArticleId><ArticleId IdType="pubmed">35614536</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C., Bellmann-Strobl J.T., Heindrich C., Wittke K., Stein E., Franke C., Pr&#xfc;ss H., Pre&#xdf;ler H., Machule M.L., Audebert H., et al. Fighting Post-COVID and ME/CFS&#x2014;Development of curative therapies. Front. Med. 2023;10:1194754. doi: 10.3389/fmed.2023.1194754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1194754</ArticleId><ArticleId IdType="pmc">PMC10309204</ArticleId><ArticleId IdType="pubmed">37396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., Filgueiras I.S., Kedor C., Freitag H., Wittke K., Bauer S., Sep&#xfa;lveda N., Mathias da Fonseca D.L., Baiocchi G.C., Marques A.H.C., et al. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front. Immunol. 2022;13:981532. doi: 10.3389/fimmu.2022.981532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.981532</ArticleId><ArticleId IdType="pmc">PMC9552223</ArticleId><ArticleId IdType="pubmed">36238301</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobasheri L., Nasirpour M.H., Masoumi E., Azarnaminy A.F., Jafari M., Esmaeili S.-A. SARS-CoV-2 triggering autoimmune diseases. Cytokine. 2022;154:155873. doi: 10.1016/j.cyto.2022.155873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155873</ArticleId><ArticleId IdType="pmc">PMC8979824</ArticleId><ArticleId IdType="pubmed">35461172</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sawalha A.H., Lu Q. COVID-19 and autoimmune diseases. Curr. Opin. Rheumatol. 2021;33:155&#x2013;162. doi: 10.1097/BOR.0000000000000776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Keka-Sylaj A., Ramosaj A., Baloku A., Zogaj L., Gjaka P. Multisystem Inflammatory Syndrome in Children (MIS-C), Possibly Due to COVID-19 mRNA Vaccination. Vaccines. 2023;11:956. doi: 10.3390/vaccines11050956.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11050956</ArticleId><ArticleId IdType="pmc">PMC10223090</ArticleId><ArticleId IdType="pubmed">37243060</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannotta G., Murrone A., Giannotta N. COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events. Vaccines. 2023;11:747. doi: 10.3390/vaccines11040747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11040747</ArticleId><ArticleId IdType="pmc">PMC10145134</ArticleId><ArticleId IdType="pubmed">37112659</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Muller S., Kanduc D., David P., Halpert G., Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun. Rev. 2021;20:102792. doi: 10.1016/j.autrev.2021.102792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Urena Neme A.P., De Camps Martinez E.R., Matos Noboa C., Guerra M.A.R., Ure&#xf1;a P., Velasquez P.E.U. Reversible Autoimmune Cardiomyopathy Secondary to a Vaccine-Induced Multisystem Inflammatory Syndrome. Cureus. 2022;14:e25170. doi: 10.7759/cureus.25170.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.25170</ArticleId><ArticleId IdType="pmc">PMC9206861</ArticleId><ArticleId IdType="pubmed">35747051</ArticleId></ArticleIdList></Reference><Reference><Citation>Santilli V., Manno E.C., Giancotta C., Rossetti C., Cotugno N., Amodio D., Rotulo G.A., Deodati A., Bianchi R., Lucignani G., et al. Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History. Vaccines. 2022;10:1136. doi: 10.3390/vaccines10071136.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071136</ArticleId><ArticleId IdType="pmc">PMC9319257</ArticleId><ArticleId IdType="pubmed">35891300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Chen T.Y.-T., Wang S.-I., Hung Y.-M., Chen H.-Y., Wei C.-C.J. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. eClinicalMedicine. 2023;56:101783. doi: 10.1016/j.eclinm.2022.101783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert S., Schmidt M., Wallukat G., Ponader R., Topf G., Rieger D., Klinge J., Vermehren J., Fusch C., Grillhoesl C., et al. Multisystem Inflammatory Syndrome in Children&#x201d; (MIS-C) after COVID-19 infection in the Metropolitan Area Nuremberg-Erlangen with a case of MIS-C like disease following SARS-CoV-2 mRNA vaccination. Z. Geburtshilfe Neonatol. 2023;227:e76&#x2013;e77.</Citation></Reference><Reference><Citation>Buchhorn R., Meyer C., Schulze-Forster K., Junker J., Heidecke H. Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? Vaccines. 2021;9:1353. doi: 10.3390/vaccines9111353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9111353</ArticleId><ArticleId IdType="pmc">PMC8618727</ArticleId><ArticleId IdType="pubmed">34835284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Ganslmayer M., Lucio M., Kruse F., Hoffmanns J., Moritz M., Rogge L., Heltmann F., Szewczykowski C., F&#xfc;rst J., et al. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment after Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front. Med. 2021;8:676554. doi: 10.3389/fmed.2021.676554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.676554</ArticleId><ArticleId IdType="pmc">PMC8299003</ArticleId><ArticleId IdType="pubmed">34307408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Are fibrinaloid microclots a cause of autoimmunity in Long COVID and other post-infection diseases? Biochem. J. 2023;480:1217&#x2013;1240. doi: 10.1042/BCJ20230241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20230241</ArticleId><ArticleId IdType="pubmed">37584410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Hosari S., Wallukat G., Kunze R., Krebs J., M&#xfc;ller M., Hennig T., L&#xe4;mmer R., Horn F., Mu&#xf1;oz L.E., et al. Agonistic autoantibodies against &#xdf;2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients. PLoS ONE. 2021;16:e0249202. doi: 10.1371/journal.pone.0249202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249202</ArticleId><ArticleId IdType="pmc">PMC8104926</ArticleId><ArticleId IdType="pubmed">33961631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Harrer T., Mardin C., Kruse F., Hoffmanns J., Rogge L., Heltmann F., Moritz M., Szewczykowski C., Schottenhamml J., et al. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms after COVID-19 Infection. Front. Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukitsch I., Kehr J., Chaykovska L., Wallukat G., Nieminen-Kelh&#xe4; M., Batuman V., Dragun D., Gollasch M. Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies. Transplantation. 2012;94:8&#x2013;13. doi: 10.1097/TP.0b013e3182529bb7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0b013e3182529bb7</ArticleId><ArticleId IdType="pubmed">22691955</ArticleId></ArticleIdList></Reference><Reference><Citation>Okruhlicova L., Morwinski R., Schulze W., Bartel S., Weismann P., Tribulova N., Wallukat G. Autoantibodies against G-protein-coupled receptors modulate heart mast cells. Cell Mol. Immunol. 2007;4:127&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17484807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>